SG3 Management’s Allergan plc AGN Stock Holding History

SG3 Management’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-93,900	Closed	-$15.7M	–	209
2018 Q2	$15.7M	Buy	+93,900	New	+$15.1M	3.57%	8
2018 Q1	–	Sell	-7,000	Closed	-$1.15M	–	154
2017 Q4	$1.15M	Hold	7,000	–	–	0.37%	49
2017 Q3	$1.44M	Hold	7,000	–	–	0.33%	63
2017 Q2	$1.7M	Hold	7,000	–	–	0.43%	68
2017 Q1	$1.67M	Sell	7,000 -4,000	-36%	-$932K	0.31%	71
2016 Q4	$2.31M	Buy	+11,000	New	+$2.28M	0.37%	50

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SG3 Management's AGN Position: Q1 2020 in Review

SG3 Management sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 1,000 shares — an estimated $191K sold.

SG3 Management first reported a position in AGN in Q4 2016 and held it in 9 quarters. The position peaked at $1.26M in Q4 2016. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

SG3 Management reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
SG3 Management sold 1,000 Allergan plc shares in Q1 2020, an estimated $191K.
SG3 Management first reported a position in Allergan plc in Q4 2016 and held it in 9 quarters.
SG3 Management's Allergan plc position peaked at $1.26M in Q4 2016.
876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on SG3 Management's 13F filing for Q1 2020, filed 12 May 2020.